Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 2OTHER_GOV 1OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Colorectal Neoplasms 260Carcinoma, Non-Small-Cell Lung 125Glioblastoma 105Breast Neoplasms 104Ovarian Neoplasms 96Carcinoma, Hepatocellular 88Brain Neoplasms 71Rectal Neoplasms 69Neoplasm Metastasis 69Lung Neoplasms 65Colonic Neoplasms 58Neoplasms 57Glioma 52Fallopian Tube Neoplasms 44Carcinoma, Renal Cell 36Gliosarcoma 31Pancreatic Neoplasms 30Melanoma 27Liver Neoplasms 26Stomach Neoplasms 21Astrocytoma 21Adenocarcinoma of Lung 21Recurrence 20Kidney Neoplasms 19Colorectal Cancer Metastatic 17Triple Negative Breast Neoplasms 16Esophageal Neoplasms 15Uterine Cervical Neoplasms 14Sarcoma 13Prostatic Neoplasms 13

Interventions

Ipilimumab 6tremelimumab 5durvalumab 5Nivolumab 3Capecitabine 3Radiotherapy 2Radiation 2Paclitaxel 2CTLA-4 Antigen 2Blood Specimen Collection 2relatlimab 1poly ICLC 1lenvatinib 1folfirinox 1balstilimab 1Vaccines 1Vaccination 1Surgical Procedures, Operative 1Radiosurgery 1Platinum 1Peptides 1Pemetrexed 1Oxaliplatin 1Opdualag 1Monophenol Monooxygenase 1Melphalan 1Leucovorin 1Immunotherapy 1Fluorouracil 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Diabetes Mellitus, Insulin-Dependent, 12 × Bevacizumab × Clear all
NCT07416058 2026-02-17

PHOENIX

Guangdong Association of Clinical Trials

Phase 2 Not yet recruiting
61 enrolled
Thoracic

Diabetes Mellitus, Insulin-Dependent, 12, Adenocarcinoma of Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡